Kenvue Should Have Raised FDA Probe Before IPO, Suit Says
By Katryna Perera · November 17, 2023, 8:25 PM EST
Pharmaceutical company Kenvue Inc. was hit with a proposed class action alleging it failed to inform investors ahead of its initial public offering about a regulatory investigation into the effectiveness of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login